Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlying immune system imbalance in people with autoimmune...
14 insider purchases on record · latest filing 2019-09-09.
Insiders have also filed 490 sale transactions at NKTR.